0 Comentários
0 Compartilhamentos
698 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
- Faça Login para curtir, compartilhar e comentar!
- Remicade Biosimilars Market Estimated To Witness High Growth Owing To Rising Prevalence Of Autoimmune DiseasesSWOT Analysis Strength: Remicade biosimilars market has strong growth potential due to the patent expiry of Remicade leading to availability of affordable treatment options. Biosimilars have almost similar efficacy as reference biologics with much lower costs. Rapid regulatory approvals for biosimilars are catalyzing their commercialization. Weakness: Development of biosimilars require...0 Comentários 0 Compartilhamentos 780 Visualizações 0 Anterior
- Remicade Biosimilars Market is Estimated to Witness High Growth Owing to Increased Use for the Treatment of Rheumatoid ArthritisRemicade is a biologic disease-modifying anti-rheumatic drug used for the treatment of various autoimmune diseases. It is primarily used for rheumatoid arthritis, Crohn's disease, ulcerative colitis. Remicade biosimilars offer effective treatment alternatives at lower costs. This has increased the use of Remicade biosimilars in recent years. The global Remicade biosimilars Market is estimated...0 Comentários 0 Compartilhamentos 718 Visualizações 0 Anterior
- Remicade Biosimilars Market is Estimated to Witness High Growth Owing to Opportunity for Cost SavingsRemicade biosimilars are gaining prominence in the biopharmaceutical industry due to their comparable safety and efficacy profile to reference drugs at a lower cost. Remicade biosimilars are used for the treatment of autoimmune and inflammatory diseases such as rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriatic arthritis and ankylosing spondylitis. The global demand for...0 Comentários 0 Compartilhamentos 757 Visualizações 0 Anterior
- Remicade Biosimilars Market Poised to Witness High Growth Due to Rising Demand for Cost-Effective BiologicsThe global Remicade Biosimilars Market is estimated to be valued at US$ 3007 million in 2023 and is expected to exhibit a CAGR of 3.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. SWOT Analysis Strength: Remicade biosimilars are nearly identical versions of original biologic drugs and provide a more...0 Comentários 0 Compartilhamentos 781 Visualizações 0 Anterior